BNR
Burning Rock Biotech LtdCompany with tickers: BNR
CIK
1792267
CUSIP
12233L206
Shares Outstanding
8,813,858
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | 537,435,000 | CNY | 2023-12-31 | 20-F | 2026-04-28 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | 174,208,000 | CNY | 2023-12-31 | 20-F | 2026-04-28 |
| Gross Profit | 363,227,000 | CNY | 2023-12-31 | 20-F | 2026-04-28 |
| Operating Expenses | — | ||||
| Research & Development | 347,016,000 | CNY | 2023-12-31 | 20-F | 2026-04-28 |
| Operating Income | -669,321,000 | CNY | 2023-12-31 | 20-F | 2026-04-28 |
| Net Income | -653,689,000 | CNY | 2023-12-31 | 20-F | 2026-04-28 |
| EPS (Basic) | — | ||||
| EPS (Diluted) | — |